Liane Pinto
Director - Clinical Development Medical & RLT Prostate Cancer Novartis AG
Seminars
Thursday 23rd July 2026
Virtual Presentation – Identifying Biomarkers to Overcome Patient Variability in 177-Lu-PSMA-617 Therapy to Guide Treatment Decisions & Optimize Outcomes in mCRPC
11:00 am
- Identifying molecular, imaging, and circulating biomarkers that explain interpatient variability in response to ^177Lu-PSMA-617
- Correlating biomarker profiles with treatment response, resistance, and toxicity to refine patient selection
- Informing treatment sequencing and personalization strategies to optimize outcomes in mCRPC
